UCLA presents advances in radiation therapy at ASTRO 2025
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results…
Nuclide Therapeutics secures over $6 million for drugs against treatment-resistance cancers
 Nuclide Therapeutics, a King’s College London spinout developing radioactive drugs to target therapy-resistant cancers, has closed a…
Preventing radiation damage with melanin-based material
 Radiotherapy for abdominal and pelvic cancers almost always leads to small-intestine injuries that are difficult to heal,…
Survey shows ongoing misconceptions about hormone therapy safety in cancer survivors
Despite evidence suggesting the safety of hormone therapy for patients with a history of low-grade endometrial or epithelial…